CONAVI MEDICAL CORP (CNVI.CA) Stock Income Statement
TSX-V:CNVI - TSX Venture Exchange - CA2059531020 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 500.00K | 17.63M | 0.00 | 20.09M | 20.00M | |||
| Operating Expenses | 3.93M | 8.68M | 44.77M | 51.08M | 15.80M | |||
| Research and Development | N/A | 321.00K | 33.01M | 37.95M | 7.94M | |||
| Selling, General, and Administrative Expenses | 4.53M | 8.18M | 10.90M | 12.43M | 7.63M | |||
| Operating Income | -3.43M | 8.95M | -44.77M | -30.99M | 4.20M | |||
| Interest Income/Expense | 177.00K | 463.00K | 4.49M | 15.58M | -29.04M | |||
| Other Income/Expense | N/A | 105.00K | 0.00 | 605.00K | -1.82M | |||
| Non Recurring Items | N/A | -2.78M | -2.32M | 0.00 | 2.47M | |||
| Income Before Taxes | -6.91M | 6.98M | -42.60M | -14.80M | -24.18M | |||
| Income Tax | N/A | 24.00K | -56.00K | 56.00K | N/A | |||
| Net Income | -6.94M | 6.95M | -42.54M | -14.86M | -24.18M | |||
| EBITDA | N/A | 9.13M | -43.91M | -30.29M | 4.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.67 | 0.06 | -0.38 | -0.14 | -0.36 | |||
| Statistics | ||||||||
| Profit Margin | -1387.40% | 39.43% | N/A | -73.95% | -120.90% | |||
| Operating Profit Margin | -686.00% | 50.75% | N/A | -154.22% | 21.00% | |||
All data in USD